Report of Allergic Reaction After Application of Botulinum Toxin
Carregando...
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS INC
Citação
AESTHETIC SURGERY JOURNAL, v.35, n.5, p.NP102-NP105, 2015
Resumo
Botulinum toxin is a widely used treatment with satisfactory results, and it is relatively safe in the doses used for cosmetic procedures. The authors report a case of allergic reaction to Chinese botulinum toxin serotype A (CBTX-A). Although this is a rare adverse event, it is nonetheless clinically relevant to healthcare professionals. A 44-year-old woman presented to the authors' hospital complaining of dynamic wrinkles. CBTX-A was used to treat her. Minutes after application, she developed urticarial plaques proximal to the injection site. The patient had an allergic reaction, as documented by a positive skin test, which was controlled by the administration of antihistamines and systemic corticosteroids. This report is intended to guide healthcare professionals faced with this type of adverse event regarding how to proceed without hindering the delivery and effectiveness of the treatment. When performed by a qualified health professional, this treatment brings excellent results in the vast majority of cases.
Palavras-chave
Referências
- Ahbib S, 2006, ANN DERMATOL VENER, V133, P43, DOI 10.1016/S0151-9638(06)70842-0
- Carruthers A, 2001, SEMIN CUTAN MED SURG, V20, P71, DOI 10.1053/sder.2001.25138
- Carruthers A, 2004, J CLIN RES, V7, P1
- Carruthers Jean, 2007, J Cosmet Laser Ther, V9, P186, DOI 10.1080/14764170701411470
- Committee for Proprietary Medicinal Products ( CPMP) and by the Committee for Veterinary Medicinal products ( CVMP), 2004, OFFICIAL J EUROPEAN, V024, P0006
- Cote TR, 2005, J AM ACAD DERMATOL, V53, P407, DOI 10.1016/j.jaad.2005.06.011
- Hatheway CL, 1993, FOOD SCI TECHNOLOGY, V54, p[3, 20]
- Institute for Vaccine Safety Web site. Johns Hopkins Bloomberg School of Public Health, ALL
- Jacob CI, 2007, SEMIN CUTAN MED SURG, V22, P131
- Jost WH, 2007, DRUGS, V67, P669, DOI 10.2165/00003495-200767050-00003
- Kamin W, 2006, KLIN PADIATR, V218, P92, DOI 10.1055/s-2005-836609
- LeWitt PA, 1997, MOVEMENT DISORD, V12, P1064, DOI 10.1002/mds.870120637
- Li M, 2005, J FORENSIC SCI, V50, P169
- Masley MV, 2007, PAEDIAT ASTHMA ALLER, V20, P201
- Pickett A, 2009, J AM ACAD DERMATOL, V61, P149, DOI 10.1016/j.jaad.2008.12.042
- Rieder CRM, 2007, CLIN NEUROPHARMACOL, V30, P39, DOI 10.1097/01.WNF.0000236771.77021.3C
- Rosenfield LK, 2014, AESTHET SURG J, V34, P766, DOI 10.1177/1090820X14532648
- Spencer J. M., 2002, COSMET LASER THER J, V4, P19
- Tamura BM, 2008, DERMATOL SURG, V34, P1117, DOI 10.1111/j.1524-4725.2008.34223.x
- U.S. Food and Drug Administration, INF HEALTHC PROF ON
- US Food and Drug Administration, SOURC PROC GEL RED P